Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 4:51 pm Purchase | 13G | THERATECHNOLOGIES INC THTX | Nantahala Capital Management LLC | 2,682,228 5.8% | 2,682,228 (New Position) | View |
| 2024-02-14 4:51 pm Sale | 13G | APTOSE BIOSCIENCES INC NO APTO | Nantahala Capital Management LLC | 120,132 1.5% | -5,932,735 (-98.02%) | View |
| 2024-02-14 4:51 pm Purchase | 13G | ESTABLISHMENT LABS HLDGS INC C ESTA | Nantahala Capital Management LLC | 2,470,154 9.6% | 526,913 (+27.12%) | View |
| 2024-02-14 4:51 pm Purchase | 13G | DARIOHEALTH CORP COM DRIO | Nantahala Capital Management LLC | 2,761,140 9.9% | 184,822 (+7.17%) | View |
| 2024-02-14 4:51 pm Purchase | 13G | RUMBLEON INC RMBL | Nantahala Capital Management LLC | 4,416,506 12.6% | 2,624,637 (+146.47%) | View |
| 2024-02-14 4:51 pm Purchase | 13G | SOLENO THERAPEUTICS INC NE SLNO | Nantahala Capital Management LLC | 3,068,031 9.9% | 2,229,497 (+265.88%) | View |
| 2024-02-14 4:51 pm Purchase | 13G | ABEONA THERAPEUTICS INC NE ABEO | Nantahala Capital Management LLC | 2,499,781 9.9% | 1,140,094 (+83.85%) | View |
| 2024-02-14 4:51 pm Purchase | 13G | VISTAGEN THERAPEUTICS INC VTGN | Nantahala Capital Management LLC | 2,797,588 9.9% | 2,797,588 (New Position) | View |
| 2024-02-14 4:51 pm Purchase | 13G | ELUTIA INC ELUT | Nantahala Capital Management LLC | 1,912,776 9.9% | 1,912,776 (New Position) | View |
| 2024-02-14 4:51 pm Purchase | 13G | INSPIREMD INC NSPR | Nantahala Capital Management LLC | 2,162,392 9.9% | 2,162,392 (New Position) | View |
| 2024-02-14 4:51 pm Purchase | 13G | ENVVENO MED CORP COM NVNO | Nantahala Capital Management LLC | 1,399,588 9.9% | 1,399,588 (New Position) | View |
| 2024-02-14 4:51 pm Purchase | 13G | ZEVRA THERAPEUTICS INC ZVRA | Nantahala Capital Management LLC | 2,453,405 6.2% | 2,453,405 (New Position) | View |
| 2024-02-14 4:51 pm Purchase | 13G | UNICYCIVE THERAPEUTICS INC UNCY | Nantahala Capital Management LLC | 3,475,713 9.9% | 2,268,297 (+187.86%) | View |
| 2024-02-14 4:51 pm Purchase | 13G | CELLECTAR BIOSCIENCES INC CLRB | Nantahala Capital Management LLC | 3,229,903 9.9% | 3,229,903 (New Position) | View |
| 2024-02-14 4:51 pm Sale | 13G | AVALO THERAPEUTICS INC AVTX | Nantahala Capital Management LLC | 42,100 4.9% | -612,574 (-93.57%) | View |
| 2024-01-22 6:46 pm Purchase | 13D | TALPHERA, INC. TLPH | Nantahala Capital Management LLC | 1,992,519 11.8% | 1,992,519 (New Position) | View |
| 2023-11-09 4:01 pm Purchase | 13G | RUMBLEON INC RMBL | Nantahala Capital Management LLC | 1,791,869 10.7% | 302,478 (+20.31%) | View |
| 2023-06-16 5:14 pm Purchase | 13D | AYTU BIOPHARMA INC PAR $0. AYTU | Nantahala Capital Management LLC | 1,086,812 19.7% | 815,217 (+300.16%) | View |
| 2023-05-26 1:52 pm Purchase | 13D | AYTU BIOPHARMA INC PAR $0. AYTU | Nantahala Capital Management LLC | 271,595 7.2% | 271,595 (New Position) | View |
| 2023-02-14 5:11 pm Purchase | 13G | APOLLO ENDOSURGERY INC APEN | Nantahala Capital Management LLC | 4,056,627 9.9% | 84,985 (+2.14%) | View |